ABCC8 and diabetes mellitus: While diabetes arising from ABCC8 and KCNJ11 requires high-dose sulfonylureas (9), a low-dose sulfonylureas is sufficient to obtain good control of blood glucose levels in the majority of HNF4A-MODY and HNF1A-MODY patients (10).